Astellas is a global pharmaceutical company dedicated to changing tomorrow by improving people’s health through developing reliable first-in-line and best-in-class therapy options in our specialization areas – Oncology, Urology, Transplantation, Anti-Infectives and Pain management.  Aiming to improve the lives of cancer patients we are focusing our R&D and partnership efforts into precision medicine – more than 12 separate innovative therapies are under clinical development targeting prostate cancer and other solid tumors like breast cancer, lung cancer, and bladder cancer, as well as hematological malignancies.